4Tech collects $29 mln in Series B financing
4Tech Inc, a developer of transcatheter treatments for Tricuspid Regurgitation, raised $29 million in a Series B funding round led by Valiance and RMM with participation from NeoMed Management. 4Tech is incorporated in Delaware, USA, with operations in Galway, Ireland
10 March 2016•2 mins read
